Both nitric oxide (NO) and carbon monoxide (CO) are vessel wall-derived messenger molecules that cause platelet inhibition and vasodilation by activating guanylyl cyclase in target cells. Since vascular smooth muscle cells (SMCs) are exposed to shear and tensile stresses, this study examined the effects of these hemodynamic forces on the enzymes that generate NO and CO in SMCs. Monolayers of cultured rat aortic SMCs were subjected to shear stress using a modified cone and plate viscometer, or cyclic elongational stretch using a compliant silastic culture membrane. Shear stress stimulated time-dependent increases in mRNA and protein for inducible heme oxygenase-1 (HO-1), the enzyme which forms CO as a byproduct of heme degradation. The threshold level of shear necessary to induce HO-1 expression was between 5 and 10 dynes/cm 2 . In contrast, shear stress did not stimulate inducible NO synthase (iNOS) expression. Cyclic stretch also induced the expression of HO-1 but not of iNOS mRNA. Exposure of vascular SMCs to shear stress stimulated the production and release of CO as demonstrated by the COdependent increase in intracellular cGMP levels in coincubated platelets. In addition, ADP-stimulated aggregation was inhibited in platelets exposed to sheared SMCs but not in platelets exposed to untreated control SMCs. Treatment of sheared SMCs with the HO-1 inhibitor, tin protoporphyrin-IX, blocked the antiaggregatory effect of the cells, whereas the iNOS inhibitor, methyl-L -arginine, had no effect. These results indicate that hemodynamic forces induce HO-1 gene expression and CO production in vascular SMCs, and that SMC-derived CO inhibits platelet aggregation. Thus, CO is a novel endogenous vessel wall-derived messenger molecule that may be selectively induced by hemodynamic forces to inhibit platelet reactivity and preserve blood fluidity at sites of vascular injury. ( J. Clin. Invest. 1997. 100:589-596.)
Introduction
The passage of blood through the cardiovascular system generates hemodynamic forces. Fluid flow across the cell surface results in shear stress, while tensile stress, which produces elongational stretch, is caused by circumferential deformations resulting from transmural pressure gradients and vascular smooth muscle tone (1) . These physical forces can alter the function of cells which comprise the vessel wall (2) . Most studies of shear stress have examined its effect on endothelial cells which line the intimal surface of the vasculature. Shear stress induces elongation of endothelial cells in the direction of flow through cytoskeletal rearrangement (3, 4) , inhibits cell proliferation (5), initiates intracellular signaling (6) (7) (8) (9) , and stimulates the synthesis and secretion of various bioactive molecules, including prostacyclin (PGI 2 ), tissue plasminogen activator, and platelet-derived growth factor (10) (11) (12) . Most studies on the effects of stretch have likewise focused on endothelial cells, and have shown that it regulates endothelin-1 (13, 14) , PGI 2 (13, 15) , tissue plasminogen activator (13, 16) , and the proto-oncogenes c-fos and c-jun. (17) . Investigations of the effect of strain on vascular smooth muscle cells have demonstrated that it induces the production of platelet-derived growth factor (18) and stimulates cell proliferation (19) (20) (21) .
Increased levels of nitric oxide (NO) 1 are also released by endothelial cells when stimulated by shear stress (22) (23) (24) or cyclic strain (25) . NO is a simple diatomic gas which is formed as a byproduct of the conversion of L -arginine to L -citrulline by NO synthases (NOS) (26) . In the circulation, the production of NO by vascular cells promotes blood flow by inhibiting smooth muscle contraction and platelet adhesion and aggregation (27). These effects of NO are mediated by the activation of soluble guanylyl cyclase and the consequent rise in guanosine 3 Ј ,5 Ј -cyclic monophosphate (cGMP) in vascular smooth muscle cells (SMCs) and platelets (28) . While endothelial cells continually release small amounts of NO through a constitutive isoform of NOS, SMCs express an inducible isotype, termed inducible NOS (iNOS), which is capable of synthesizing large quantities of NO (29) .
A second diatomic gas molecule, carbon monoxide (CO), which is produced as a byproduct of heme catabolism to biliverdin by heme oxygenase (HO), has many of the same properties as NO. It stimulates the production of cGMP by interacting with the heme moiety of guanylyl cyclase (30) . Like NO, CO causes blood vessel relaxation and platelet inhibition through a cGMP-dependent mechanism (31, 32) . We have reported recently that vascular SMCs express two isoforms of HO, an inducible form (HO-1) and a constitutive form (HO-2) (33). HO-1 is induced by its substrate, heme, as well as other diverse stimuli, including metal-containing compounds such as sodium arsenite (NaAs) (34, 35) .
SMCs are continually exposed to cyclic strain due to pulsatile blood flow. Vascular circumferential elongation under nor-mal physiologic conditions at peak systole ranges between 2 and 18% depending on the vessel of interest (36, 37) . However, elongation for a particular vessel may be slightly larger in hypertensive states (38) . SMCs are also directly exposed to blood flow and shear stress at sites of vascular damage caused by the rupture of atherosclerotic lesions or invasive techniques such as balloon angioplasty. Furthermore, interstitial fluid flow from the blood stream to the tunica media transmits shear stress to SMCs even in intact blood vessels. Theoretical calculations of the shear stress levels induced by this fluid flow have predicted SMC exposure to shear stress levels of 2-3 dynes/ cm 2 , with further elevated levels under pathophysiological conditions (39, 40) . SMCs stimulated by different humoral mediators are capable of producing NO and CO through activation of iNOS and HO-1, respectively, and both gases inhibit platelet aggregation and smooth muscle contraction by activating soluble guanylyl cyclase. In this study we determined whether physiologically relevant hemodynamic forces induce iNOS and/or HO-1 expression, leading to the production of platelet inhibitory NO and/or CO by vascular SMCs. Induction of these enzymes and the subsequent release of guanylyl cyclase-stimulatory gases by hemodynamic forces could potentially modulate vascular tone and platelet reactivity, thereby regulating blood fluidity at sites of vascular damage.
Methods
Materials. Adenosine diphosphate (ADP), cycloheximide, fibrillar type I collagen, guanidine isothiocyanate (GITC), sarkosyl, sodium dodecyl sulfate (SDS), sodium nitroprusside (SNP), ␤ -mercaptoethanol, trichloroacetic acid, N G -methyl-L -arginine (L-NMA), bovine serum albumin, N -tris[hydroxymethyl]methyl-2-aminoethane sulfonic acid (TES) and N -2-hydroxyethylpiperazine-N Ј -2-ethane sulfonic acid (Hepes) buffers, ethyleneglycol-bis-N , N Ј -tetraacetic acid (EGTA), minimal essential media, and NaAS were purchased from Sigma Chemical Co. (St. Louis, MO). Fetal calf serum (FCS), cell culture trypsin, penicillin, streptomycin, and neomycin were purchased from GIBCO BRL (Gaithersburg, MD). Recombinant murine interleukin-1 ␤ (IL-1 ␤ ) was purchased from R&D Systems (Minneapolis, MN). Tin protoporphyrin-IX (SnPP-IX) was purchased from Porphyrin Products, Inc. (Logan, UT). Actinomycin D was purchased from Boehringer Mannheim (Indianapolis, IN). [ SMC culture. Rat aortic SMCs were provided by Dr. Tim ScottBurden at the University of Texas in Houston. They were isolated from rat thoracic aorta using standard enzymatic digestion methods and characterized as described elsewhere (41) . Stock cells were passaged and grown in minimum essential media supplemented with 10% (vol/vol) heat-inactivated FCS, 4 mM glutamine, 50 mg/liter penicillin, 50 mg/liter streptomycin, 100 mg/liter neomycin, 2 mM TES, and 2 mM Hepes. Cells to be used in experiments were seeded on glass plates for exposure to shear stress or compliant silastic membranes for exposure to cyclic strain. The surfaces were precoated with collagen type I at ‫ف‬ 15 g collagen/cm 2 and allowed to grow to confluence. Collagen solutions were prepared from insoluble fibrillar type I collagen dissolved in 3% glacial acetic acid, homogenized, with impurities separated by centrifugation. Collagen concentration was determined by hydroxyproline assay, described elsewhere (42).
Shear stress experimental conditions. Before treatment, SMCs were placed on serum-free media (same as above with 0.1% bovine serum albumin instead of 10% FCS) for 12 h. The cells were then sheared in a modified cone and plate viscometer using a 1 Њ cone (Ferranti Electric, Inc., Commack, NY). Cultures were maintained at 37 Њ C by heating from below with a circulating water bath, and the atmosphere was regulated with humidified 5% CO 2 /air mixture during the experiment. This system is similar to that used by Dewey and his colleagues to study shear stress effects on cultured endothelial cells. Unsheared control plates were treated for 24 h with serum-free media only as a negative control, and with NaAs (10 M) to induce HO-1 expression or IL-1 ␤ (5 ng/ml) to induce iNOS expression as positive controls. SnPP-IX (30 M) was used to inhibit HO-1 and was added 1.5 h before the end of treatment while L-NMA (1 mM) was added for the entire treatment period to inhibit iNOS.
Cyclic strain experimental conditions. The cells, grown on a taut silastic membrane, were treated with serum-free media for 24 h as described above. The stretch apparatus is similar to that used by Carosi et al. (43) . Briefly, the membrane is fixed at one end with the other attached to a piston which passes through the culture chamber wall. The piston is repeatedly pulled by a mechanical device on which the frequency and stroke distance can be set. A motion control apparatus is set up in parallel in which the membrane is attached to a ridged frame. The frame is connected to the piston but the other end is free to move, providing a control for the movement of media induced by the sliding piston. Confluent monolayers of SMC were stretched at a 10% level for up to 24 h at 60 cycles/min (1 Hz).
mRNA analysis. Total cellular RNA was prepared by scrape-harvesting the SMCs into GITC solution (4 M GITC, 25 mM sodium citrate, 5% sarkosyl, pH 7.0) containing 0.1 M ␤ -mercaptoethanol. RNA was isolated by centrifugation through a 5.7 M cesium chloride cushion at 100,000 g for 22 h. The RNA pellet was washed, precipitated overnight, and resuspended in Tris-EDTA buffer (10 mM TrisHCl, 1 mM EDTA, pH 7.6). RNA concentration was determined by absorbance spectrophotometry at 260 nm.
mRNA for iNOS and HO-1 was detected by RNase protection assay using a commercially available kit from Ambion Inc. (Austin, TX). cDNA probe templates for both HO-1 (285 bp) and iNOS (160 bp) were produced from total rat SMC RNA by reverse transcriptionpolymerase chain reaction using primers based on published sequences for the two genes (44, 45) . The antisense RNA probe was generated in the presence of [ 32 P]UTP by in vitro transcription. Total RNA (10-15 g) was hybridized with 2-4 ϫ 10 5 cpm of the riboprobe, and the protection assay was performed according to the procedure outlined in the kit manual. The labeled RNA was separated on a 6% acrylamide/8 M urea denaturing polyacrylamide gel. The gel was dried and exposed to x-ray film at Ϫ 70 Њ C in the presence of intensifying screens. The size of the predicted nucleotide-protected fragments was confirmed by using a 32 P-labeled RNA ladder. Protein analysis. Cellular protein was prepared by scrape-harvesting SMCs into cold phosphate-buffered saline (PBS). The cells were centrifuged at 2,000 g for 2 min, and the pellet was resuspended in cell sample buffer (12 mM Tris-HCl, pH 6.8, 5% glycerol, and 0.4% SDS), boiled for 10 min, sonicated in a water bath for 15 min, and then centrifuged at 10,000 g for 10 min. The supernatant was saved, and protein concentrations were determined using the bicinchoninic acid protein assay by Pierce Chemical Co. (Rockford, IL).
Cell protein extracts were separated by polyacrylamide gel electrophoresis under reducing conditions using separation gels of 20% acrylamide for HO-1 and 10% for iNOS. The proteins were transferred to nitrocellulose membranes and detected using an enhanced chemiluminescence Western blotting kit from Amersham Corp. After blocking with 5% nonfat milk, HO-1 was detected using a polyclonal antibody at a 1:500 dilution. iNOS was detected using a primary monoclonal antibody at a 1:2,500 dilution. Horseradish peroxidase-conjugated secondary antibodies were used at 1:7,500 and 1:5,000 dilution for HO-1 and iNOS, respectively, and the bands were visualized after exposure to photographic film.
Platelet detector system. Human platelets were isolated from whole blood anticoagulated with 1:7 acid citrate dextrose (ACD, NIH Formula A) drawn from healthy donors. The platelets were washed in Tyrode's buffer (137 mM NaCl, 2.8 mM KCl, 0.42 mM NaH 2 PO 4 , and 12 mM NaHCO 3 ), and finally a washed platelet suspension containing 2.5 ϫ 10 8 platelets/ml was prepared in JNL buffer (6 mM dextrose, 130 mM NaCl, 9 mM NaHCO 3 , 10 mM sodium citrate, 10 mM Tris base, 3 mM KCl, 2 mM Hepes, and 0.9 mM MgCl 2 ). The medium was aspirated from SMCs which had been treated and washed twice with PBS to remove inducers and inhibitors which might affect the platelets. The SMCs were then overlaid with 3 ml of platelet suspension ( ‫ف‬ 1.5 ϫ 10 7 platelets/cm 2 ) and allowed to coincubate for 5 min. The platelets were removed from the cell monolayers and added to an equivalent volume of trichloroacetic acid (6% final concentration). The platelet-acid suspensions were sonicated and assayed for cGMP using a commercially available radioimmunoassay kit (DuPont NEN, Boston, MA). To control for variability in platelet responsiveness between experiments, a separate platelet sample from each experiment was exposed to the guanylyl cyclase activator SNP (50 M for 5 min), and results were expressed as a percentage of SNPinduced cGMP elevation. We have previously used increases in cGMP levels in platelets treated in this manner to indicate the production of CO by SMCs (33) .
In some experiments, washed rat platelets were isolated from ACD anticoagulated rat whole blood. Platelet-rich plasma was obtained by centrifugation at 110 g for 20 min followed by 10 min at 1,800 g to pellet the platelets. The pellet was resuspended in Tyrode's buffer supplemented with 0.35% (wt/vol) bovine albumin (pH 6.6 with HCl) and 0.5 mM EGTA. The platelets were again pelleted, and the final platelet suspension was prepared in JNL buffer.
Platelet aggregation analysis. Washed platelet suspensions were prepared as above and treated for 1 h with 100 M aspirin. After aspirating the media, SMCs were washed twice with PBS and then overlaid with the platelet suspension and coincubated for 5 min. The platelets were removed and placed in an aggregometer and checked for their ability to aggregate in response to 10 M ADP. Aggregometry tracings were recorded by computer, and the level of aggregation was corroborated using particle counting, checking both pre-and post-aggregated suspensions.
Statistical analysis. Results are expressed as the means Ϯ SEM. Significant difference between means was computed using a paired Student's t test with significance defined as P Ͻ 0.05.
Results
Exposure of SMCs to a shear stress of 20 dynes/cm 2 induced the expression of HO-1 mRNA (Fig. 1 A ) . HO-1 mRNA expression was observed as early as 1 h after the onset of shear stress, and HO-1 message progressively increased over a period of 24 h (Fig. 1 A ) . In contrast, shear stress failed to induce iNOS mRNA expression in SMCs (Fig. 1 A ) . In control experiments, treatment of SMCs with a known inducer of HO-1 (NaAs; 10 M) or iNOS (IL-1 ␤ ; 5 ng/ml) for 24 h under nonshear conditions stimulated HO-1 and iNOS mRNA expression, respectively (Fig. 1 A ) . Similarly, exposure of SMCs to 10% stretch at 60 cycles/min (1 Hz) induced HO-1 mRNA expression without inducing iNOS (Fig. 1 B ) . Motion control experiments performed in parallel failed to induce either HO-1 or iNOS mRNA expression (Fig. 1 B ) .
The induction of HO-1 mRNA expression by shear stress was dependent on the magnitude of shear stress. A threshold level between 5 and 10 dynes/cm 2 was required to induce HO-1 mRNA levels, and higher levels of shear stress further increased the amount of HO-1 message (Fig. 2) . In all instances, the level of ␤ -actin mRNA remained constant, confirming equal loading of RNA ( Fig. 1 A and Fig. 2) .
Shear stress (20 dynes/cm 2 ) also increased the amount of HO-1 protein in SMCs without inducing iNOS protein expression (Fig. 3) . The shear-mediated increase in HO-1 protein was dependent on the length of shear exposure, with a maximal increase observed after 24 h of stimulation (Fig. 3) . Treatment of SMCs with actinomycin D (2 g/ml) or cycloheximide (5 g/ml) blocked shear-induced HO-1 mRNA and protein expression, respectively (data not shown).
To examine the relative induction of HO-1 by cyclic strain compared to fluid dynamic shear stress, SMC responses to these two hemodynamic mechanisms were examined simultaneously. Fig. 4 A shows the induction of HO-1 protein stimulated by exposure of SMCs to shear stress of 20 dynes/cm 2 for 24 h, and to cyclic strain of 10% at 1 Hz for 24 h. The magnitude of protein expression is 4.7-fold greater in the shearinduced SMCs than in the stretch-induced SMCs, as determined by densitometry (Fig. 4 B ) .
In subsequent experiments, HO activity was measured by monitoring SMC CO production. Since CO is a readily diffusible membrane-soluble gas which is known to activate soluble guanylyl cyclase (30, 32) , HO activity was determined by measuring the intracellular concentration of cGMP in coincubated detector platelets. Incubating platelets with SMCs which had been exposed to shear stress (20 dynes/cm 2 for 6 h) significantly increased platelet cGMP concentration compared to control unsheared SMCs (Fig. 5) . Similarily, incubation of platelets with NaAs-(10 M for 24 h) or IL-1 ␤ -treated (5 ng/ml for 24 h) but unsheared SMCs also elevated platelet cGMP levels (Fig. 5) . Recovery of platelets after incubation with SMCs averaged ‫ف‬ 82% under all conditions: 82.4 Ϯ3.9% for untreated, 79.9Ϯ1.2% for IL-1␤-treated, 84.3Ϯ2.6% for NaAs-treated, and 82.2Ϯ3.3% for shear-treated SMCs. The stimulatory effect on platelet cGMP concentration by either shear or NaAstreated SMCs was blocked by incubating the SMCs with the HO-1 inhibitor, SnPP-IX (30 M). In contrast, treatment of SMCs with the iNOS inhibitor, L-NMA (1 mM), did not inhibit the elevation of platelet cGMP induced by shear, and caused only a slight decrease in NaAs-treated SMCs (Fig. 5) . However, either L-NMA (1 mM) or SnPP-IX (30 M) partially reversed the stimulatory effect on platelet cGMP evoked by IL-1␤-treated SMCs (Fig. 5) . The combined addition of L-NMA (1 mM) and SnPP-IX (30 M) to IL-1␤-treated SMCs completely inhibited the stimulatory effect on platelet cGMP levels (data not shown). To examine the potential scavenging effect of hemoglobin on CO released from SMCs, experiments were performed using platelets in whole blood instead of washed suspensions in the platelet detector system. In these experiments, cGMP was measured in platelet-rich plasma prepared from whole blood after exposure to SMCs. Although there was a consistent and reproducible increase in platelet cGMP levels from whole blood exposed to shear stress-stimulated SMCs (20 dynes/cm 2 for 24 h), the increase was not statistically significant (data not shown).
Additional experiments were performed to determine if the results of these platelet-SMC interactions were a function of species differences (human platelets and rat SMCs). Rat platelet suspensions were therefore used in coincubation ex- periments with rat aortic SMCs exposed to shear stress. Elevations in rat platelet cGMP levels were observed to be comparable and consistent with the increases demonstrated in human platelet suspensions (data not shown).
Finally, the ability of shear stress to stimulate the production of a platelet-inhibitory substance by vascular SMCs was examined. ADP (10 M) produced a submaximal and irreversible aggregation of aspirin-treated platelets within 3 min (Fig. 6) . Coincubation of platelets with untreated control SMCs minimally affected platelet aggregation in response to ADP (Fig. 6) . Coincubation of platelets with SMCs which had been exposed to shear stress (20 dynes/cm 2 for 6 h) inhibited ADP-induced platelet aggregation. Likewise, NaAs-(10 M for 24 h) or IL-1␤-treated (5 ng/ml for 24 h) but unsheared SMCs blocked platelet aggregation in response to ADP (Fig.  6) . Finally, coincubation of sheared or NaAs-treated SMCs with the HO-1 inhibitor, SnPP-IX (30 M), reversed the antiaggregatory effect of the SMCs (Fig. 6 A) . In contrast, the iNOS inhibitor, L-NMA (1 mM), reversed the platelet inhibitory effect of only IL-1␤-stimulated, but not shear-stimulated SMCs (Fig. 6 B) .
Discussion
Flow-induced vasodilation is thought to be mediated principally through PGI 2 and NO (46) (47) (48) . Both shear stress (11, 22, 49) and cyclic strain (25, 43) induce the production of these two autocoids from endothelial cells. This study demonstrates that the physiologically relevant hemodynamic forces, shear stress and cyclic strain, selectively induce the expression of HO-1 in SMCs which may contribute to flow-induced vasodilation through the production of the novel mediator CO (31) .
Shear stress-induced HO-1 gene expression is dependent on de novo RNA and protein synthesis and is associated with the release of a biologically active substance, presumably CO, Figure 5 . cGMP levels in detector platelets exposed to SMCs. SMCs treated with serum-free media, 5 ng/ml IL-1␤, 10 M NaAs for 24 h, or 6 h of exposure to shear stress at 20 dynes/cm 2 , were coincubated for 5 min with washed platelet suspensions. NO and CO production from the SMCs were detected by increased levels of cGMP in the platelets. Washed platelets which had not been exposed to any stimulus were analyzed to determine the basal level of cGMP, and platelets treated with 50 M SNP were used to determine the maximum level of cGMP attainable for each suspension. All treatments were performed either in the absence of inhibitors (open bars), with 1 mM L-NMA (shaded bars), or 30 M SnPP-IX (solid bars). *Significant elevation in cGMP in response to treatment over serum-free negative control (P Ͻ 0.01). † Significant inhibitor-mediated reduction in cGMP levels (P Ͻ 0.05). n ϭ 4-6. Figure 6 . Platelet inhibition by shear-induced CO from SMCs. Washed platelets were coincubated for 5 min with SMCs treated with serum-free media, IL-1␤ (5 ng/ml), or NaAs (10 M) for 24 h or SMCs exposed to 20 dynes/cm 2 shear stress for 6 h. In some experiments, SnPP-IX (30 M) was added to the SMCs 1.5 h before coincubation with platelets (A). In other experiments, L-NMA (1 mM) was added for the entire treatment period (B). The SMCs were treated for 1 h with 100 M aspirin to inhibit prostacyclin production. After coincubation, the platelets were placed in an aggregometer and stimulated with 10 M ADP. A control curve of ADP-induced aggregation in platelets not exposed to SMCs is also shown. This figure is representative of three independent experiments. which activates guanylyl cyclase in platelets and inhibits ADPstimulated platelet aggregation. In addition, the induction of SMC CO release by shear stress and cyclic strain is specific to gaseous autocoid production since these forces failed to induce iNOS gene expression. The effects of cyclic strain were specific for this hemodynamic stimulus since parallel motion controls failed to induce HO-1 mRNA expression.
The molecular mechanism by which shear stress and cyclic strain regulate gene expression is not well understood. Cyclic strain may be sensed through integrin connections to the extracellular matrix since soluble Arg-Gly-Glu peptides have been shown to block SMC PDGF production by stretch (50) . Recently, a 6-bp sequence, GAGACC, was determined to be a shear stress response element (SSRE) in the promoter of several genes responsive to shear stress (51) . The SSRE may be the binding site for transcription factors activated by shear stress. In particular, Resnick et al. (52) showed that shear stress activates nuclear factor-B in endothelial cells and that this nuclear factor specifically binds to the SSRE. Interestingly, based on the published sequence, the HO-1 promoter possesses an SSRE (53); however, we cannot definitively conclude that signaling occurs through this SSRE in shear-activated SMCs since genes lacking this SSRE have been shown to be induced by shear stress. Shyy et al. demonstrated that a cisacting phorbol ester (TPA)-responsive element not containing the above sequence was necessary for shear stress induction of monocyte chemotactic protein-1 (54) .
HO-1 is known to be activated by alterations in temperature and is classified as a heat-shock protein (34) . The temperature of the media in the plates during shear stress exposure was maintained at 37ЊC with a circulating water bath below the plate. The temperature was monitored and remained between 36.8 and 37.2ЊC throughout the period of shear. Stretching experiments were performed inside a cell culture incubator maintained at 37ЊC. Thus, it is unlikely that the observed induction of HO-1 is a heat-shock response.
Vascular SMCs can be exposed to shear stress levels of at least 20 dynes/cm 2 when directly exposed to blood flow after deep vessel-wall injury. However, even SMCs within the intact vessel wall are exposed directly to flow (and wall shear stress) driven by the transmural pressure gradient (39) . Fluid movement through the interstitial spaces of the intact vessel wall, which continually provides nutrients to the surrounding tissue (55), generates shear stress in a manner similar to blood flow through vessels. Because the transmural pressure gradient is relatively low, the potentially important effects of shear stress on SMCs have been largely ignored in the past. Calculations indicate that SMCs are likely to be exposed to shear stress levels as high as 2-3 dynes/cm 2 in intact blood vessels (39) . However, changes in hydraulic conductivity across the endothelial cell lining and pathologic conditions resulting in elevations of blood pressure will dramatically increase the shear stress exerted on the SMCs. We have demonstrated that shear stress levels approaching these magnitudes are capable of inducing HO-1 gene expression. Thus, shear stress-mediated induction of HO-1 expression and CO release by vascular SMCs may be a physiologically relevant response which is not limited to pathophysiologic situations of direct SMC exposure to blood flow after injury.
Similarly, circumferential stretch as a result of pulsatile flow is sensed continuously by the vascular wall, with levels ranging from 2 to 18% (36, 37), and individual vessels may have larger strains than normal in hypertensive states (38) . The expression of HO-1 induced by (patho)physiologic levels of stretch studied here may be a process by which to decrease intraluminal pressures through vasodilation. Thus, both shear stress-and cyclic strain-induced HO-1 expression may play a role in maintaining vascular tone.
A previously described platelet detection system was used to detect CO released from SMCs (33) . Elevated levels of platelet cGMP were observed when platelets were coincubated with SMCs previously exposed to shear stress. The failure of shear stress to upregulate iNOS indicated that NO release was unlikely to contribute to the increased platelet cGMP levels under these conditions. Furthermore, the specific iNOS inhibitor, L-NMA, did not block the rise in platelet cGMP evoked by SMCs exposed to shear stress. In contrast, the HO-1 inhibitor SnPP-IX inhibited the stimulatory effect on platelet cGMP concentration induced by sheared SMCs. (Similarly, SnPP-IX was able to eliminate the increase in platelet cGMP levels induced by SMC exposed to the HO-1 inducer, NaAs.) These results indicate that only HO-1 is induced by shear stress, and that SMC-derived CO elevates cGMP levels in coincubated platelets.
Incubation of platelets with IL-1␤-treated SMCs also increased platelet cGMP levels. The NOS inhibitor, L-NMA, only partially blocked this effect, suggesting that in addition to NO other guanylyl cyclase-stimulatory mediators may be involved. In this regard, our Western blotting experiments demonstrated that IL-1␤ also stimulates HO-1 protein expression, confirming a recent study that showed that IL-1␤ induces the transcriptional activation of the HO-1 gene in vascular SMC (56), and suggesting that SMC CO release may be involved. Our finding that the combined addition of L-NMA and SnPP-IX completely reversed the elevation in cGMP levels in platelets coincubated with IL-1␤-treated SMCs is consistent with this observation and indicates that cytokine-treated SMCs are capable of increasing platelet cGMP concentration via the simultaneous release of CO and NO.
Although the increase in platelet cGMP levels was dampened when red blood cells (RBCs) were included in the coincubation, they were still consistently elevated. The observed reduction in whole blood is presumably due to the binding of CO to hemoglobin. The precise physiologic impact of CO scavenging by hemoglobin is unknown since platelets tend to be localized in flowing blood at the periphery of the vessel, displaced from the center by the mass of RBCs (57) . Therefore platelets in contact with the vessel wall in vivo may be more affected by CO (and NO) than this in vitro study suggests. Furthermore, modulation of vascular tone by the abluminal release of CO in response to shear and stretch would not be dampened by RBCs and hemoglobin.
The potential physiological relevance of shear stress-induced HO-1 gene expression was demonstrated by the capacity of endogenously released CO to inhibit platelet aggregation. Incubation of platelets with sheared SMCs blocked ADP-stimulated platelet aggregation. This antiaggregatory effect was not mediated by prostacyclin, since SMC cyclooxygenase was inhibited by aspirin before the experiment. L-NMA completely reversed the platelet inhibitory effects of IL-1␤-treated SMCs, indicating that SMC-derived NO mediates the antiaggregatory effect under these conditions. However, the inhibition of platelet aggregation by sheared SMCs was prevented by treating the SMCs with SnPP-IX but not with L-NMA, indicating that only CO released by sheared SMCs mediates platelet inhibition. This is consistent with earlier studies showing that exogenously added CO inhibits platelet aggregation, and indicates that CO is of potential physiological importance as a regulator of platelet reactivity (32) .
In conclusion, we have demonstrated that hemodynamic forces induce the expression of HO-1. Normal arterial levels of shear stress selectively induce HO-1 gene expression and CO production in vascular SMCs. Even though the actions and putative physiologic roles of CO are similar to those of NO, the induction of HO-1 by shear stress and cyclic strain in SMCs does not appear to be a redundant regulatory mechanism since iNOS was not induced under the same conditions. In addition, this study demonstrates that SMCs exposed to shear stress can inhibit platelet aggregation via the release of CO. Thus, CO released endogenously from vascular cells exposed to physiologically and pathophysiologically relevant hemodynamic forces may represent a novel messenger molecule that modulates the state of blood fluidity in the circulation.
